These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 10072521

  • 1. A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2.
    Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S, Kohashi O.
    J Immunol; 1999 Mar 01; 162(5):2754-60. PubMed ID: 10072521
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system.
    Xu LX, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T.
    J Cell Physiol; 1995 Dec 01; 165(3):624-9. PubMed ID: 7593242
    [Abstract] [Full Text] [Related]

  • 3. IL-4, but not vitamin D(3), induces monoblastic cell line UG3 to differentiate into multinucleated giant cells on osteoclast lineage.
    Kaji Y, Ikeda K, Ikeda T, Kawakami K, Sasaki K, Shindo M, Hatake K, Harada M, Motoyoshi K, Mori S, Norimatsu H, Takahara J.
    J Cell Physiol; 2000 Feb 01; 182(2):214-21. PubMed ID: 10623885
    [Abstract] [Full Text] [Related]

  • 4. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM, Nishioka K, Yudoh K.
    Ann Rheum Dis; 2004 Nov 01; 63(11):1379-86. PubMed ID: 15479886
    [Abstract] [Full Text] [Related]

  • 5. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):97-102. PubMed ID: 10334922
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W.
    Bone; 2006 Aug 27; 39(2):325-35. PubMed ID: 16580896
    [Abstract] [Full Text] [Related]

  • 8. Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor.
    Kukita T, Kukita A, Nagata K, Maeda H, Kurisu K, Watanabe T, Iijima T.
    J Immunol; 1994 Dec 01; 153(11):5265-73. PubMed ID: 7963580
    [Abstract] [Full Text] [Related]

  • 9. Osteoclastogenesis is decreased by cysteine proteinase inhibitors.
    Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH.
    Bone; 2004 Mar 01; 34(3):412-24. PubMed ID: 15003789
    [Abstract] [Full Text] [Related]

  • 10. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G, Shaw A, Oursler MJ.
    Exp Cell Res; 2004 Mar 10; 294(1):149-58. PubMed ID: 14980510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IL-18 induces apoptosis of adherent bone marrow cells in TNF-alpha mediated osteoclast formation in synergy with IL-12.
    Kitaura H, Tatamiya M, Nagata N, Fujimura Y, Eguchi T, Yoshida N, Nakayama K.
    Immunol Lett; 2006 Sep 15; 107(1):22-31. PubMed ID: 16875741
    [Abstract] [Full Text] [Related]

  • 13. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M, Uchiyama S.
    J Cell Biochem; 2005 Mar 01; 94(4):794-803. PubMed ID: 15578574
    [Abstract] [Full Text] [Related]

  • 14. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA.
    J Pathol; 2006 Jan 01; 208(1):35-43. PubMed ID: 16278818
    [Abstract] [Full Text] [Related]

  • 15. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD, Sabokbar A, Howie DW, Murray DW, Athanasou NA.
    J Orthop Res; 1999 Sep 01; 17(5):686-94. PubMed ID: 10569477
    [Abstract] [Full Text] [Related]

  • 16. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
    Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL, Goodman SB.
    Cytokine; 2004 May 07; 26(3):138-44. PubMed ID: 15135808
    [Abstract] [Full Text] [Related]

  • 17. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A, Kudo O, Athanasou NA.
    J Orthop Res; 2003 Jan 07; 21(1):73-80. PubMed ID: 12507582
    [Abstract] [Full Text] [Related]

  • 18. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR.
    Arthritis Rheum; 2000 Feb 07; 43(2):250-8. PubMed ID: 10693863
    [Abstract] [Full Text] [Related]

  • 19. A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts.
    Notoya M, Arai R, Katafuchi T, Minamino N, Hagiwara H.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):234-9. PubMed ID: 17328890
    [Abstract] [Full Text] [Related]

  • 20. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.
    Bone; 2006 May 10; 38(5):678-85. PubMed ID: 16309985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.